Advanced Enzyme Recommends ₹1.35 Dividend, Approves FY26 Results

Advanced Enzyme Technologies Ltd's board approved the annual financial results (standalone and consolidated) for FY26 and recommended a final dividend of ₹1.35 per share (67.5%) subject to shareholder approval at the upcoming AGM. The board deferred the declaration of an interim dividend to preserve capital for strategic opportunities. The board also approved the reappointment of Mr. Mukund Madhusudan Kabra as Whole Time Director for another 5 years and the appointment of Mr. Pradip Bhailal Shah as an Additional Director (Independent) for 5 years, both subject to shareholder approval. Additionally, M S K A & Associates LLP were reappointed as Statutory Auditors for a second term of 5 years, also subject to shareholder approval. The board approved the allotment of 49,350 Equity Shares under ESOP 2022, increasing the paid-up share capital to ₹22,39,52,300.